Yukie Tsuji

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 2

Top Topics

Prognostic Factors

Diffuse Large B Cell Lymphoma

Top Venues

Hematological oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Kenji Ishitsuka, Tomoharu Yasukawa, Yukie Tsuji
Safety and effectiveness of mogamulizumab in relapsed or refractory CC chemokine receptor 4-positive peripheral T-cell lymphoma and relapsed or refractory cutaneous T-cell lymphoma: A post-marketing surveillance in Japan. Hematological oncology 42 (4) (2024)
Kenji Ishitsuka, Tomoharu Yasukawa, Yukie Tsuji
Safety and effectiveness of mogamulizumab in relapsed or refractory CC chemokine receptor 4-positive peripheral T-cell lymphoma and relapsed or refractory cutaneous T-cell lymphoma: A post-marketing surveillance in Japan. Hematological oncology 42 (4) (2024)